Harmony Biosciences
HRMY
HRMY
202 hedge funds and large institutions have $2.27B invested in Harmony Biosciences in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 106 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7.47% more ownership
Funds ownership: 80.7% → 88.18% (+7.5%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
1% less capital invested
Capital invested by funds: $2.29B → $2.27B (-$22.3M)
Holders
202
Holding in Top 10
7
Calls
$5.72M
Puts
$398K
Top Buyers
| 1 | +$71.1M | |
| 2 | +$40.3M | |
| 3 | +$36.7M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$18.7M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$16M |
Top Sellers
| 1 | -$51.2M | |
| 2 | -$30.7M | |
| 3 | -$19.7M | |
| 4 |
VP
venBio Partners
San Francisco,
California
|
-$14.3M |
| 5 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
-$7.82M |